Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Saurabh Saha
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focus |
immunology
oncology rare diseases |
| gptkbp:foundedYear |
2021
|
| gptkbp:founder |
Saurabh Saha
|
| gptkbp:headquartersLocation |
gptkb:United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Centessa Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
LB101
OXA-01 serpinPC |
| gptkbp:numberOfEmployees |
100-200
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:CNTA
|
| gptkbp:website |
https://www.centessa.com/
|
| gptkbp:bfsParent |
gptkb:Stephen_Squinto
|
| gptkbp:bfsLayer |
7
|